Literature DB >> 2076800

Underestimation of glucose turnover determined using [6-3H]glucose tracer in non-steady state. The role of a tritiated tracer impurity.

R D Neely1, D P Rooney, A B Atkinson, B Sheridan, C N Ennis, E R Trimble, P M Bell.   

Abstract

The use of tritiated glucose tracers may result in underestimation of glucose turnover during hyperinsulinaemic clamps giving paradoxical negative endogenous glucose production rates. While mathematical modelling errors in the analysis of tracer data are major determinants of this underestimate in the non-steady state, the relative importance of tracer contamination under these conditions remains in doubt. We have used high performance liquid chromatography to assess the possible contribution to this problem of a labelled tracer impurity found in [6-3H]glucose. In conventional 4 h hyperinsulinaemic clamps performed in six normal subjects, labelled impurity increased as a percentage of the neutral plasma radioactivity fraction from 5.3 +/- 0.9% after a 2 h equilibration period (0 min) to 13.5 +/- 2.2% at 120 min and 15.4 +/- 2.4% at 240 min, as plasma glucose specific activities fell following the infusion of insulin. Negative endogenous glucose production rates were observed both at 90-120 min (-8.8 +/- 1.6 mumol.kg-1min-1) and at 210-240 min (-8.5 +/- 1.4 mumol.kg-1min-1) implying a persistent underestimate in isotopically determined glucose appearance rate. Using chromatography data to correct for impurity increased glucose appearance rates by 7.9 +/- 2.1% at 120 min and 11.0 +/- 2.5% at 240 min. Purified tracer was then used for a further six clamps. When the conventional protocol was used with unlabelled glucose infusion an obvious negative error persisted only at 90-120 min. In contrast, labelled infusions gave exclusively positive values for endogenous glucose production.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076800     DOI: 10.1007/BF00400570

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

3.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method.

Authors:  R STEELE; J S WALL; R C DE BODO; N ALTSZULER
Journal:  Am J Physiol       Date:  1956-09

4.  Nonenzymatic glycosylation of proteins. A warning.

Authors:  B Trüeb; C G Holenstein; R W Fischer; K H Winterhalter
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

Review 5.  Assessment of insulin sensitivity in vivo.

Authors:  R N Bergman; D T Finegood; M Ader
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

6.  Enhanced glucose utilization during prolonged glucose clamp studies.

Authors:  L Doberne; M S Greenfield; B Schulz; G M Reaven
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

7.  Hepatic glucose output in humans measured with labeled glucose to reduce negative errors.

Authors:  J C Levy; G Brown; D R Matthews; R C Turner
Journal:  Am J Physiol       Date:  1989-10

8.  Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used.

Authors:  P M Bell; R G Firth; R A Rizza
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Underestimation of glucose turnover measured with [6-3H]- and [6,6-2H]- but not [6-14C]glucose during hyperinsulinemia in humans.

Authors:  M M McMahon; W F Schwenk; M W Haymond; R A Rizza
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

10.  Mechanism for underestimation of isotopically determined glucose disposal.

Authors:  H Yki-Järvinen; A Consoli; N Nurjhan; A A Young; J E Gerich
Journal:  Diabetes       Date:  1989-06       Impact factor: 9.461

View more
  6 in total

1.  A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM.

Authors:  R Harper; C N Ennis; A P Heaney; B Sheridan; M Gormley; A B Atkinson; G D Johnston; P M Bell
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

2.  Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity.

Authors:  Jason J Winnick; W Michael Sherman; Diane L Habash; Michael B Stout; Mark L Failla; Martha A Belury; Dara P Schuster
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

3.  Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D P Rooney; R D Neely; O Beatty; N P Bell; B Sheridan; A B Atkinson; E R Trimble; P M Bell
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

4.  Metabolic handling of orally administered glucose in cirrhosis.

Authors:  Y T Kruszynska; A Meyer-Alber; F Darakhshan; P D Home; N McIntyre
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.

Authors:  R Harper; C N Ennis; B Sheridan; A B Atkinson; G D Johnston; P M Bell
Journal:  BMJ       Date:  1994-07-23

6.  Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover study.

Authors:  E M McMurray; I R Wallace; C Ennis; S J Hunter; A B Atkinson; P M Bell
Journal:  J Hum Hypertens       Date:  2014-04-17       Impact factor: 3.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.